This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
shared her perspective on a number of topics affecting nuclearmedicine, ranging from isotope availability and reimbursement challenges for diagnosticradiopharmaceuticals to increasing patient interest in PET imaging. In a recent interview, Cathy Cutler, Ph.D.,
With therapeutic radiopharmaceuticals coming to market quickly and available to smaller institutions around the U.S., My vision of a theranostic center includes a flagship facility that has a PET/CT scanner, a SPECT/CT scanner, and then multiple rooms for infusions of radiopharmaceuticals," Siegel explained.
Anderson , PhD, a trailblazer in nuclearmedicine, has been named the 2024 recipient of the Georg Charles de Hevesy Nuclear Pioneer Award. The award was announced by the Society of NuclearMedicine and Molecular Imaging (SNMMI) during its 2024 Annual Meeting, June 8-11 in Toronto.
As nuclearmedicine therapies gain stature compared to nuclearmedicine in diagnosticimaging, hospital administrators may be eyeing the potential of adding theranostics services. Image courtesy of Washington University. "We This oversight has led to program launch setbacks, Beyder explained.
Campione also joins the Blue Earth Diagnostics Ltd. “I The Company is a recognized leader throughout the nuclearmedicine and oncology communities, having a strong reputation grounded in successful innovation, execution and dedicated service on behalf of patient health,” he added. Bracco Imaging S.p.A.,
An assistant professor of radiology and radiological science, Francis Deng, MD, is the Johns Hopkins radiology department's co-director of medical student diagnostic radiology electives. His area of expertise is neuroradiology, with a special emphasis on diagnosticimaging of the head, neck, brain, and spine. Elliot Fishman, MD.
Teleradiology-India Introduction: Nuclearmedicine continues to be at the forefront of cutting-edge technologies, pushing the boundaries of diagnostic and therapeutic capabilities. Revolutionary Radioisotopes: Expanding the Diagnostic Toolkit: Explore the latest developments in novel radioisotopes used in nuclearmedicine.
Teleradiology & Radiology data for artificial intelligence (AI) Introduction: Nuclearmedicine, a dynamic and rapidly evolving field, continues to break new ground in diagnostic and therapeutic approaches. Introduction to NuclearMedicine: Merging Physics and Medicine: Provide an overview of nuclearmedicine.
milla1cf Thu, 06/29/2023 - 21:10 June 29, 2023 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, today announced highlights from early clinical and preclinical studies of 177Lu-rhPSMA-10.1 Blue Earth Diagnostics received U.S.
produced, non-uranium based Mo-99 for use in diagnosticimaging. Mr. Merrick continued, “Demand for therapeutic radiopharmaceuticals is increasing rapidly. NorthStar has further deepened and broadened our business platform with the recent establishment of a full-scale radiopharmaceutical CDMO/CMO services unit.
Be sure to visit us at our virtual booth Thursday, September 30 through Saturday, October 2 to learn more about our complete nuclearmedicine and molecular imaging solutions. For the latest updates on TTG Imaging Solutions, connect with us on LinkedIn , Twitter , and Facebook.
Be sure to visit us at our virtual booth Saturday, October 30 and Sunday, October 31 to learn more about our complete nuclearmedicine and molecular imaging solutions. For the latest updates on TTG Imaging Solutions, connect with us on LinkedIn , Twitter , and Facebook.
About TTG Imaging Solutions TTG Imaging Solutions is your partner for nuclearmedicine and molecular imaging solutions that includes equipment sales, nationwide service, parts, turnkey diagnosticimaging, and radiopharmaceuticals.
NuclearMedicine and Theranostics : Nuclearmedicine radiologists specialize in advanced imaging techniques, such as PET/CT scans, to detect and treat conditions at the molecular level. They also lead the field in theranostics , which combines diagnostics and therapy in one procedure.
More than half of the world’s population is underserved and lacks access to essential health services, and two-thirds have no access to diagnosticimaging. Product life extension & upgrades GE HealthCare is also proud to offer global refurbished medical equipment, helping to improve access to affordable, quality healthcare.
About TTG Imaging Solutions TTG Imaging Solutions is your partner for nuclearmedicine and molecular imaging solutions that includes equipment sales, nationwide service, parts, turnkey diagnosticimaging, and radiopharmaceuticals.
Martin Shirley was appointed the role of TTG Imaging Solutions Executive Vice President Sales, Marketing & Clinical Operations in April of 2023 as part of TTG Imaging Solutions acquisition of Digirad Health, Inc and its subsidiaries Digirad DiagnosticImaging, Inc and Digirad Imaging Solution, Inc.
Martin Shirley was appointed the role of TTG Imaging Solutions Executive Vice President Sales, Marketing & Clinical Operations in April of 2023 as part of TTG Imaging Solutions acquisition of Digirad Health, Inc and its subsidiaries Digirad DiagnosticImaging, Inc and Digirad Imaging Solution, Inc.
PITTSBURGH, PA (November 1, 2021) – TTG Imaging Solutions, LLC (TTG) announced today executive leadership changes that will drive the company’s next phase of growth following its 9th acquisition in 2 years of Medical Imaging Technologies, an Akron, Ohio based nuclearmedicine equipment and service organization.
Enhances TTG’s continued commitment to offer a full spectrum of high-quality and cost-effective service solutions in the cardiology and radiation oncology markets PITTSBURGH, PA (May 5, 2023) – TTG Imaging Solutions, LLC (TTG) announced today the acquisition of Digirad Health, Inc., headquartered in Suwanee, GA. Digirad Health, Inc.
A dedicated teacher and radiologic technologist since 2009, Stewart currently serves as associate professor of diagnosticimaging, and program director of radiologic sciences at Quinnipiac University in Connecticut. from Ukraine.
Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval.
Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content